Literature DB >> 7705942

International patterns in the occurrence of Hodgkin's disease in children and young adult males.

G J Macfarlane1, T Evstifeeva, P Boyle, S Grufferman.   

Abstract

It was reported over 20 years ago that there were distinct age-specific patterns of Hodgkin's disease incidence in countries with different levels of economic development, and that there was an inverse relationship between the incidence of Hodgkin's disease in children and young adults within countries. Such observations were important, leading to hypotheses on the possibly infectious aetiology of the disease. Since the initial report, diverging trends in the incidence of Hodgkin's disease in children and young adults have been observed, and data from a much larger number of countries and cancer registries have become available. This led us to reassess international age-related incidence patterns of Hodgkin's disease occurrence. Recent data show distinct differences in age-specific Hodgkin's disease incidence patterns in different geographic regions. In general, the United States (US) and European countries had the pattern of low childhood rates and high young adulthood rates. However, countries which are not part of the European Union (EU), mainly Baltic states and countries of central and eastern Europe, showed a variant of this pattern: similarly high young adult rates, but rates in children higher than those in the US and EU. Incidence-rate patterns for Latin American countries differed from those previously observed, with a shift towards patterns observed in more economically developed countries. Analysis of incidence data from earlier sources dating back to 1963 confirmed the original finding of an inverse association in incidence rates (c. 1963-1967) using a selected group of cancer registries, but not when all data were considered. This association has become weaker over the past 20 years. Using current incidence rates (1983-1987), no association between Hodgkin's disease rates in children aged 5 to 14 years (as well as 0 to 9 years) and young adults (20 to 34 years) was found.

Entities:  

Mesh:

Year:  1995        PMID: 7705942     DOI: 10.1002/ijc.2910610204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Epidemiology and pathologic features of Hodgkin lymphoma.

Authors:  Shin-ichi Nakatsuka; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 2.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

3.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

4.  Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary.

Authors:  Zsófia Miltényi; Zsófia Simon; Edit Páyer; László Váróczy; Lajos Gergely; Adám Jóna; Arpád Illés
Journal:  ISRN Hematol       Date:  2011-12-01

Review 5.  Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.

Authors:  Massimiliano Salati; Marina Cesaretti; Matteo Macchia; Mufid El Mistiri; Massimo Federico
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-01       Impact factor: 2.576

6.  Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.

Authors:  Mounia Elidrissi Errahhali; Manal Elidrissi Errahhali; Redouane Boulouiz; Meryem Ouarzane; Mohammed Bellaoui
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430

7.  Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.

Authors:  S L Glaser; C A Clarke; E T Chang; J Yang; S L Gomez; T H Keegan
Journal:  Cancer Causes Control       Date:  2014-04-11       Impact factor: 2.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.